ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,977Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 1111

$748K Total Retail Price of All Prescriptions

Rank: 88 out of 1111

433 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 433 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 433 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 10,728 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 620 511 1 3
HYDROCODONE-ACETAMINOPHEN 558 383 S3 2 1
LISINOPRIL 481 385 3 2
OMEPRAZOLE 444 333 4 4
FUROSEMIDE 394 352 5 6
POTASSIUM CHLORIDE 388 346 6 9
METFORMIN HCL 300 234 7 8
SIMVASTATIN 265 209 8 5
AMLODIPINE BESYLATE 252 213 9 7
GABAPENTIN 235 184 10 10
ATORVASTATIN CALCIUM 234 201 11 15
METOPROLOL SUCCINATE 227 198 12 20
ZOLPIDEM TARTRATE 211 132 13 16
SERTRALINE HCL 210 179 14 24
TRAMADOL HCL 201 146 15 13
WARFARIN SODIUM 198 158 16 19
LOSARTAN POTASSIUM 171 157 17 34
HYDROCHLOROTHIAZIDE 153 129 18 11
MELOXICAM 151 112 19 18
CARVEDILOL 146 140 20 21
CLOPIDOGREL 142 127 21 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 131 99 22 23
POLYETHYLENE GLYCOL 3350 130 120 23 45
NEXIUM 129 66 24 26
TAMSULOSIN HCL 125 103 25 28
CYMBALTA 120 73 26 40
PLAVIX 119 114 27 49
DONEPEZIL HCL 115 115 28 25
PREMARIN 112 75 R 29 90
FENTANYL 109 29 S2 30 65
PRAVASTATIN SODIUM 108 88 31 17
RANITIDINE HCL 105 78 32 29
FLUTICASONE PROPIONATE 105 49 32 27
GLIMEPIRIDE 104 72 34 61
ATENOLOL 103 100 35 22
TRAZODONE HCL 99 70 36 32
LOSARTAN-HYDROCHLOROTHIAZIDE 99 91 36 72
DILTIAZEM ER 92 87 38 158
METOPROLOL TARTRATE 90 76 39 12
LYRICA 90 90 39 62
DIOVAN 89 72 41 51
CITALOPRAM HBR 87 66 42 14
DILTIAZEM 24HR CD 87 72 42 152
ALLOPURINOL 84 69 44 36
METOLAZONE 82 49 45 162
CRESTOR 82 70 45 33
IBUPROFEN 81 37 47 66
NAMENDA 81 81 47 31
MIRTAZAPINE 80 55 49 52
ISOSORBIDE MONONITRATE ER 78 78 50 73
CLONIDINE HCL 77 65 51 42
LANTUS 77 49 51 46
SPIRONOLACTONE 76 70 53 83
MEGESTROL ACETATE 75 55 R 54 103
AZITHROMYCIN 71 56 55 39
OXYCODONE HCL-ACETAMINOPHEN 69 40 S2 56 86
LIPITOR 66 48 57 116
DIGOXIN 63 63 58 47
TIZANIDINE HCL 63 38 58 91
CYCLOBENZAPRINE HCL 61 21 R 60 37
ROPINIROLE HCL 60 30 61 68
CIPROFLOXACIN HCL 58 40 62 58
CELEBREX 57 53 63 81
PAROXETINE HCL 57 50 63 55
COMBIVENT 57 24 63 129
AMLODIPINE BESYLATE-BENAZEPRIL 56 46 66 67
ALENDRONATE SODIUM 55 55 67 35
ADVAIR DISKUS 55 46 67 43
CARISOPRODOL 54 0 R 69 54
AVODART 54 54 69 216
MECLIZINE HCL 52 37 71 162
BENICAR 52 52 71 227
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.